<DOC>
	<DOCNO>NCT00455533</DOCNO>
	<brief_summary>The study evaluate effectiveness ixabepilone give doxorubicin plus cyclophosphamide ( AC ) compare standard treatment paclitaxel give doxorubicin plus cyclophosphamide patient early stage breast cancer . In addition study verify predefined biomarkers well discover new biomarkers could identify patient likely respond ixabepilone standard paclitaxel base therapy .</brief_summary>
	<brief_title>Study Assess Effectiveness Giving Combination Standard Chemotherapy Drugs Versus Combination Standard Chemotherapy New Drug Ixabepilone When Given Before Surgical Removal Early Stage Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Epothilones</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<criteria>Inclusion criterion Histologically confirm primary invasive adenocarcinoma breast , T23 , N03 , M0 , tumor size ≥ 2 cm All patient early stage breast adenocarcinoma may enroll irrespective receptor status No prior treatment breast cancer exclude therapy DCIS Karnofsky performance status 80 100 leave ventricular ejection fraction ( LVEF ) ≥ 50 % echocardiogram multiple gate acquisition ( MUGA ) Adequate hematologic , hepatic renal function Exclusion Criteria woman childbearing potential ( WOCBP ) unwilling unable use acceptable method avoid pregnancy 8 week last dose investigational drug Women pregnant breastfeed Inflammatory metastatic breast cancer Unfit breast and/or axillary surgery Evidence baseline sensory motor neuropathy Significant history cardiovascular disease , serious intercurrent illness infection include know human immu immunodeficiency virus ( HIV ) infection History prior anthracycline therapy Allergies study medication Cremophor® EL</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Early Breast Cancer</keyword>
</DOC>